Associated Papers
Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross-sectional study in 684 melanoma patients.
Manrique-Silva E et al.
Pigment Cell & Melanoma Research, 2024
TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma.
Giunco S et al.
Frontiers in Oncology, 2021
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.
Del Bianco P et al.
Cancers, 2020
TERT promoter mutation subtypes and survival in stage I and II melanoma patients.
Andrés-Lencina JJ et al.
International Journal of Cancer, 2019
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients.
Ofner R et al.
Journal of Cancer Research and Clinical Oncology, 2017
TERT promoter mutations are rare in parathyroid tumors.
Haglund F et al.
Endocrine-related Cancer, 2015
Select a paper to view details